The clinical spectrum of heterozygous protein C deficiency in a large New England kindred
- PMID: 2521802
The clinical spectrum of heterozygous protein C deficiency in a large New England kindred
Abstract
A family with a high incidence of venous thromboembolism was investigated. We performed medical evaluations on 184 of the 411 surviving members of the pedigree, which allowed assignment of individuals into positive, equivocal, or negative categories with respect to their clinical histories of thrombosis. Subjects with antigenic levels of protein C less than 66% of a normal plasma pool were classified as having protein C deficiency. Positive thrombotic histories were found in 13 of the 46 family members determined to be protein-C deficient and in only five of their 138 biochemically unaffected relatives. Statistical analysis of the association between thromboembolic disease and protein-C deficiency was strongly positive chi 2 = 24.95, P less than .0001 with n = 184), indicating that heterozygous protein-C deficiency is an important independent risk factor for the development of thrombotic manifestations in this pedigree. However, the absence of thromboembolic manifestations in many of the protein-C deficient family members to date indicates that other, as yet undefined, factors must play an important role in the clinical expression of this disorder.
Similar articles
-
Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency.Blood. 1988 May;71(5):1418-26. Blood. 1988. PMID: 2965928
-
The G20210A prothrombin polymorphism is not associated with increased thromboembolic risk in a large protein C deficient kindred.Thromb Haemost. 2000 Mar;83(3):366-70. Thromb Haemost. 2000. PMID: 10744139
-
Heterozygous protein C deficiency type I.Blut. 1989 Apr;58(4):201-6. doi: 10.1007/BF00320774. Blut. 1989. PMID: 2706323
-
[The genetics of thrombosis].Haematologica. 1991 Jun;76 Suppl 3:249-60. Haematologica. 1991. PMID: 1836447 Review. Italian. No abstract available.
-
[Hereditary deficiency of antithrombin III, protein C and protein S. A study of 31 patients from 8 unrelated families].Ann Fr Anesth Reanim. 1990;9(6):485-94. doi: 10.1016/s0750-7658(05)80220-5. Ann Fr Anesth Reanim. 1990. PMID: 2177589 Review. French.
Cited by
-
Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications.Biologics. 2008 Jun;2(2):285-96. doi: 10.2147/btt.s1954. Biologics. 2008. PMID: 19707361 Free PMC article.
-
A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy.Breast Cancer Res Treat. 1996;40(2):151-9. doi: 10.1007/BF01806210. Breast Cancer Res Treat. 1996. PMID: 8879681 Clinical Trial.
-
Whole-exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease.Blood. 2020 Jul 30;136(5):533-541. doi: 10.1182/blood.2019004161. Blood. 2020. PMID: 32457982 Free PMC article.
-
The prothrombotic phenotypes in familial protein C deficiency are differentiated by computational modeling of thrombin generation.PLoS One. 2012;7(9):e44378. doi: 10.1371/journal.pone.0044378. Epub 2012 Sep 12. PLoS One. 2012. PMID: 22984498 Free PMC article.
-
An unknown genetic defect increases venous thrombosis risk, through interaction with protein C deficiency.Am J Hum Genet. 1998 Aug;63(2):569-76. doi: 10.1086/301947. Am J Hum Genet. 1998. PMID: 9683579 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources